PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 50,000 shares... Read more

PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results

MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. Updates since our last earnings release Achieved record fourth quarter revenues of $36.0 million reflecting growth of 33% compared to the prior year period and grew the Sequel II/IIe... Read more

FRANK JIMENEZ NAMED VICE PRESIDENT & GENERAL COUNSEL FOR GE HEALTHCARE

BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more

FRANK JIMENEZ NAMED VICE PRESIDENT & GENERAL COUNSEL FOR GE HEALTHCARE

BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more

BETTY LARSON NAMED CHIEF PEOPLE OFFICER FOR GE HEALTHCARE

BOSTON – February 8, 2022 – GE (NYSE: GE) announced the appointment of Betty Larson as Chief People Officer of GE Healthcare effective March 1, 2022. Betty will be responsible for GE Healthcare’s Human Resources and Communications teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Betty will be a critical partner as we... Read more

Xylem Reports Fourth Quarter and Full-Year 2021 Earnings

Full-year organic growth, adjusted EBITDA margin expansion, adjusted earnings per share in line with November guidance Full-year revenue of $5.2 billion, up 7% on a reported basis, up 4% organically Full-year reported earnings per share of $2.35, up 68%; adjusted earnings per share of $2.49, up 21% Strong demand drives continuing commercial momentum in all... Read more

BD REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL RESULTS

FRANKLIN LAKES, N.J., Feb. 3, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021. “Our first quarter results reflect continued execution of our BD2025 strategy and strong base business performance from all three segments.... Read more